Camila Higueras-Callejón
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Camila Higueras-Callejón has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Flora Martínez-Pecino
2 shared publications- Isabel Ruiz-Pérez
Escuela Andaluza de Salud Pública, Granada, Spain
2 shared publications - Jesús Henares-Montiel
Escuela Andaluza de Salud Pública, Granada, Spain
2 shared publications - Ana Ching-López
Affiliations Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain, Escuela Andaluza de Salud Pública (EASP), Granada, Spain, CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain
1 shared publication Ana I. Fernández-Díaz
Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain
1 shared publicationCarmen Salcedo-Sánchez
Biblioteca, Agencia Sanitaria Alto Guadalquivir, Hospital de Montilla, Montilla, Córdoba, España
1 shared publication
Latest Publications
- Open Access
- 25 May 2026
- Published by Elsevier in Preventive Medicine Reports
- Vol. 67, 103512
Cultural factors and suicide: A proposal for taxonomy
- 25 May 2026
- Published by Elsevier in Preventive Medicine Reports
- Vol. 67, 103512
Open AccessCultural factors and suicide: A proposal for taxonomy
- 28 May 2024
- Published by Wiley in Journal of Nursing Scholarship
- Vol. 56 (5) , 638-652
Systematic review of healthcare interventions for reducing gender‐based violence impact on the mental health of women with disabilities
Purpose: Women with disabilities are more exposed to violence. The health sector has a key role in all three levels of prevention of violence against women. The objective of this paper was to review the interventions for preventing gender‐based violence and reducing its impact on the mental health of women with any form of disability.Method: Relevant studies were identified through conducting searches in PubMed, Scopus, CINAHL, PsyInfo, Social Services Abstracts, and PILOTS. Two reviewers analyzed and selected studies. A qualitative synthesis was made.Results: 3149 references were obtained, among which eight articles describing nine interventions from the USA and the UK. Most were intended for women with mental/intellectual disability and assessed intimate partner or sexual violence. Only one study showed high methodological quality. They were found to be particularly effective as regards improvement of the skills acquired by participants, but the results as regards improved mental health are not consistent.Conclusion: Our review shows very little evidence of effective interventions. Further studies are required with higher internal validity and female sample groups with diverse disabilities.Clinical Relevance: Gender‐based violence is a highly prevalent problem for women with disabilities, and in addition to being a public health challenge is a violation of human rights. Health care systems and policymakers should take a key role in all three levels of prevention of violence against women with disabilities. Interventions with longer follow‐up times are required. It is also important for interventions to be designed in consultation with people with disabilities.
- 28 May 2024
- Published by Wiley in Journal of Nursing Scholarship
- Vol. 56 (5) , 638-652
Systematic review of healthcare interventions for reducing gender‐based violence impact on the mental health of women with disabilities
Purpose: Women with disabilities are more exposed to violence. The health sector has a key role in all three levels of prevention of violence against women. The objective of this paper was to review the interventions for preventing gender‐based violence and reducing its impact on the mental health of women with any form of disability.Method: Relevant studies were identified through conducting searches in PubMed, Scopus, CINAHL, PsyInfo, Social Services Abstracts, and PILOTS. Two reviewers analyzed and selected studies. A qualitative synthesis was made.Results: 3149 references were obtained, among which eight articles describing nine interventions from the USA and the UK. Most were intended for women with mental/intellectual disability and assessed intimate partner or sexual violence. Only one study showed high methodological quality. They were found to be particularly effective as regards improvement of the skills acquired by participants, but the results as regards improved mental health are not consistent.Conclusion: Our review shows very little evidence of effective interventions. Further studies are required with higher internal validity and female sample groups with diverse disabilities.Clinical Relevance: Gender‐based violence is a highly prevalent problem for women with disabilities, and in addition to being a public health challenge is a violation of human rights. Health care systems and policymakers should take a key role in all three levels of prevention of violence against women with disabilities. Interventions with longer follow‐up times are required. It is also important for interventions to be designed in consultation with people with disabilities.
- Open Access
- 20 October 2022
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 19 (10) , e1004110
The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis
Background: Longer time intervals to diagnosis and treatment are associated with worse survival for various types of cancer. The patient, diagnostic, and treatment intervals are considered core indicators for early diagnosis and treatment. This review estimated the median duration of these intervals for various types of cancer and compared it across high- and lower-income countries. Methods and findings: We conducted a systematic review with meta-analysis (prospectively registered protocol CRD42020200752). Three databases (MEDLINE, Embase, and Web of Science) and information sources including grey literature (Google Scholar, OpenGrey, EThOS, ProQuest Dissertations & Theses) were searched. Eligible articles were published during 2009 to 2022 and reported the duration of the following intervals in adult patients diagnosed with primary symptomatic cancer: patient interval (from the onset of symptoms to first presentation to a healthcare professional), diagnostic interval (from first presentation to diagnosis), and treatment interval (from diagnosis to treatment start). Interval duration was recorded in days and study medians were combined in a pooled estimate with 95% confidence intervals (CIs). The methodological quality of studies was assessed using the Aarhus checklist. A total of 410 articles representing 68 countries and reporting on 5,537,594 patients were included. The majority of articles reported data from high-income countries (n = 294, 72%), with 116 (28%) reporting data from lower-income countries. Pooled meta-analytic estimates were possible for 38 types of cancer. The majority of studies were conducted on patients with breast, lung, colorectal, and head and neck cancer. In studies from high-income countries, pooled median patient intervals generally did not exceed a month for most cancers. However, in studies from lower-income countries, patient intervals were consistently 1.5 to 4 times longer for almost all cancer sites. The majority of data on the diagnostic and treatment intervals came from high-income countries. Across both high- and lower-income countries, the longest diagnostic intervals were observed for hematological (71 days [95% CI 52 to 85], e.g., myelomas (83 days [47 to 145])), genitourinary (58 days [50 to 77], e.g., prostate (85 days [57 to 112])), and digestive/gastrointestinal (57 days [45 to 67], e.g., colorectal (63 days [48 to 78])) cancers. Similarly, the longest treatment intervals were observed for genitourinary (57 days [45 to 66], e.g., prostate (75 days [61 to 87])) and gynecological (46 days [38 to 54], e.g., cervical (69 days [45 to 108]) cancers. In studies from high-income countries, the implementation of cancer-directed policies was associated with shorter patient and diagnostic intervals for several cancers. This review included a large number of studies conducted worldwide but is limited by survivor bias and the inherent complexity and many possible biases in the measurement of time points and intervals in the cancer treatment pathway. In addition, the subintervals that compose the diagnostic interval (e.g., primary care interval, referral to diagnosis interval) were not considered. Conclusions: These results identify the cancers where diagnosis and treatment initiation may take the longest and reveal the extent of global disparities in early diagnosis and treatment. Efforts should be made to reduce help-seeking times for cancer symptoms in lower-income countries. Estimates for the diagnostic and treatment intervals came mostly from high-income countries that have powerful health information systems in place to record such information.
- 20 October 2022
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 19 (10) , e1004110
Open AccessThe patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis
Background: Longer time intervals to diagnosis and treatment are associated with worse survival for various types of cancer. The patient, diagnostic, and treatment intervals are considered core indicators for early diagnosis and treatment. This review estimated the median duration of these intervals for various types of cancer and compared it across high- and lower-income countries. Methods and findings: We conducted a systematic review with meta-analysis (prospectively registered protocol CRD42020200752). Three databases (MEDLINE, Embase, and Web of Science) and information sources including grey literature (Google Scholar, OpenGrey, EThOS, ProQuest Dissertations & Theses) were searched. Eligible articles were published during 2009 to 2022 and reported the duration of the following intervals in adult patients diagnosed with primary symptomatic cancer: patient interval (from the onset of symptoms to first presentation to a healthcare professional), diagnostic interval (from first presentation to diagnosis), and treatment interval (from diagnosis to treatment start). Interval duration was recorded in days and study medians were combined in a pooled estimate with 95% confidence intervals (CIs). The methodological quality of studies was assessed using the Aarhus checklist. A total of 410 articles representing 68 countries and reporting on 5,537,594 patients were included. The majority of articles reported data from high-income countries (n = 294, 72%), with 116 (28%) reporting data from lower-income countries. Pooled meta-analytic estimates were possible for 38 types of cancer. The majority of studies were conducted on patients with breast, lung, colorectal, and head and neck cancer. In studies from high-income countries, pooled median patient intervals generally did not exceed a month for most cancers. However, in studies from lower-income countries, patient intervals were consistently 1.5 to 4 times longer for almost all cancer sites. The majority of data on the diagnostic and treatment intervals came from high-income countries. Across both high- and lower-income countries, the longest diagnostic intervals were observed for hematological (71 days [95% CI 52 to 85], e.g., myelomas (83 days [47 to 145])), genitourinary (58 days [50 to 77], e.g., prostate (85 days [57 to 112])), and digestive/gastrointestinal (57 days [45 to 67], e.g., colorectal (63 days [48 to 78])) cancers. Similarly, the longest treatment intervals were observed for genitourinary (57 days [45 to 66], e.g., prostate (75 days [61 to 87])) and gynecological (46 days [38 to 54], e.g., cervical (69 days [45 to 108]) cancers. In studies from high-income countries, the implementation of cancer-directed policies was associated with shorter patient and diagnostic intervals for several cancers. This review included a large number of studies conducted worldwide but is limited by survivor bias and the inherent complexity and many possible biases in the measurement of time points and intervals in the cancer treatment pathway. In addition, the subintervals that compose the diagnostic interval (e.g., primary care interval, referral to diagnosis interval) were not considered. Conclusions: These results identify the cancers where diagnosis and treatment initiation may take the longest and reveal the extent of global disparities in early diagnosis and treatment. Efforts should be made to reduce help-seeking times for cancer symptoms in lower-income countries. Estimates for the diagnostic and treatment intervals came mostly from high-income countries that have powerful health information systems in place to record such information.
- Open Access
- 1 January 2021
- Published by Elsevier in Gaceta Sanitaria
- Vol. 35 (1) , 102-103
El bibliotecario como coautor de revisiones y síntesis de evidencia
- 1 January 2021
- Published by Elsevier in Gaceta Sanitaria
- Vol. 35 (1) , 102-103
Open AccessEl bibliotecario como coautor de revisiones y síntesis de evidencia
- 8 January 2020
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 127 (5) , 537-547
Intimate partner violence and perinatal health: a systematic review
Background: Physical, psychological and sexual intimate partner violence (IPV) has been described in the literature as different types of IPV experienced by women during pregnancy all over the world.Objectives: To review and summarise systematically the empirical evidence on the links between IPV during pregnancy and the perinatal health of mothers and fetuses/neonates.Search strategy: MEDLINE (Ovid), CINAHL, Embase, Nursing@ovid (Ovid) and LILACS were searched (2008–2018).Selection criteria: Observational studies that examined perinatal health outcomes (i.e. pre‐term birth, low birthweight, miscarriage, perinatal death and premature rupture of membranes) in pregnant women exposed to IPV.Data collection and analysis: Information on study characteristics, type of IPV measured, study design, methodological quality and outcome variable extracted.Results: Fifty studies were included. Twenty‐nine analysed undifferentiated IPV (n = 25 489), 34 included physical IPV (n = 7333), 22 analysed psychological IPV (n = 7833) and 18 examined sexual IPV (n = 2388). Fifteen studies were from Asia, 12 from North America and Oceania, and 12 from Central and South America. The studies examined the association between IPV and 39 different perinatal health outcomes. The most frequent outcomes reported were pre‐term birth (50%), low birthweight (46%), miscarriage (30%), perinatal death (20%) and premature rupture of membranes (20%). A significant association with perinatal health outcomes was reported by 12 of the studies analysing undifferentiated IPV, 18 physical IPV, six psychological IPV and two sexual IPV.Conclusions: The relation between IPV and perinatal health outcomes can be seen in different epidemiological designs and countries. In all, 39 different outcomes were identified and 29 were associated with IPV.Tweetable A variety of poor perinatal health outcomes are associated with psychological, physical and sexual IPV.
- 8 January 2020
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 127 (5) , 537-547
Intimate partner violence and perinatal health: a systematic review
Background: Physical, psychological and sexual intimate partner violence (IPV) has been described in the literature as different types of IPV experienced by women during pregnancy all over the world.Objectives: To review and summarise systematically the empirical evidence on the links between IPV during pregnancy and the perinatal health of mothers and fetuses/neonates.Search strategy: MEDLINE (Ovid), CINAHL, Embase, Nursing@ovid (Ovid) and LILACS were searched (2008–2018).Selection criteria: Observational studies that examined perinatal health outcomes (i.e. pre‐term birth, low birthweight, miscarriage, perinatal death and premature rupture of membranes) in pregnant women exposed to IPV.Data collection and analysis: Information on study characteristics, type of IPV measured, study design, methodological quality and outcome variable extracted.Results: Fifty studies were included. Twenty‐nine analysed undifferentiated IPV (n = 25 489), 34 included physical IPV (n = 7333), 22 analysed psychological IPV (n = 7833) and 18 examined sexual IPV (n = 2388). Fifteen studies were from Asia, 12 from North America and Oceania, and 12 from Central and South America. The studies examined the association between IPV and 39 different perinatal health outcomes. The most frequent outcomes reported were pre‐term birth (50%), low birthweight (46%), miscarriage (30%), perinatal death (20%) and premature rupture of membranes (20%). A significant association with perinatal health outcomes was reported by 12 of the studies analysing undifferentiated IPV, 18 physical IPV, six psychological IPV and two sexual IPV.Conclusions: The relation between IPV and perinatal health outcomes can be seen in different epidemiological designs and countries. In all, 39 different outcomes were identified and 29 were associated with IPV.Tweetable A variety of poor perinatal health outcomes are associated with psychological, physical and sexual IPV.
- 1 July 2010
- Published by Elsevier in Patient Education and Counseling
- Vol. 80 (1) , 10-20
Interventions to promote the use of advance directives: An overview of systematic reviews
- 1 July 2010
- Published by Elsevier in Patient Education and Counseling
- Vol. 80 (1) , 10-20
Interventions to promote the use of advance directives: An overview of systematic reviews
- 8 October 2008
- Published by Wiley
Interventions for promoting the use of advance directives for end-of-life decisions in adults
- 8 October 2008
- Published by Wiley
Interventions for promoting the use of advance directives for end-of-life decisions in adults